Endonasal Dacryocystorhinostomy Outcomes: A Tertiary Center Study

Chronic tearing, a common ailment, often stems from a blockage of the nasolacrimal duct – the pathway draining tears from the eye to the nose. For individuals where conservative treatments fail, a surgical procedure called endonasal dacryocystorhinostomy (DCR) offers a solution. Recent research, published in Cureus, examines whether using a silicon stent during this minimally invasive surgery improves outcomes. The study, conducted at a tertiary referral center in central India, compared the success rates of DCR with and without stenting over a 12-month follow-up period.

Understanding Endonasal Dacryocystorhinostomy

Traditional dacryocystorhinostomy involved an external incision, but the endonasal approach, utilizing endoscopes – thin, flexible tubes with cameras – has become increasingly popular. This endoscopic technique minimizes scarring and recovery time. The procedure essentially creates a new pathway for tear drainage, bypassing the blocked nasolacrimal duct. As explained in the Cureus publication, this evolution is linked to advancements in otorhinolaryngological surgeries, offering increased ease and reduced complications.

The study focused on patients diagnosed with chronic dacryocystitis, an inflammation of the tear sac caused by nasolacrimal duct obstruction. Researchers enrolled 60 patients, dividing them into two groups: 30 who received a silicon stent (specifically a Prison silicone nasolacrimal duct stent) during surgery and 30 who did not. All surgeries were performed by a single senior surgeon using Olympus endoscopes and monitoring equipment between October 2021 and September 2022. A key exclusion criterion was any prior DCR surgery or existing sinonasal disease.

Similar Success Rates with or Without Stents

The core finding of the study is that there was no statistically significant difference in success rates between the stented and non-stented groups. At six months post-surgery, the success rate was 90% for those with stents and 93.3% for those without (p-value 0.64). This trend continued at 12 months, with success rates of 80% and 76.6% respectively (p-value 0.71). Success was determined by evaluating the patency – or openness – of the rhinostomy opening during endoscopic examination. At the 12-month mark, 93.3% of stented patients and 90% of non-stented patients exhibited a patent opening.

It’s key to understand what “success rate” means in this context. The study doesn’t detail the specific criteria used to define success beyond the patency of the rhinostomy opening. So it doesn’t necessarily reflect a complete absence of symptoms like tearing or discomfort, only that the surgically created drainage pathway remained open. Further research would be needed to assess patient-reported outcomes and quality of life improvements.

What Does This Mean for Patients?

The findings suggest that, for patients with chronic dacryocystitis undergoing endonasal DCR, the routine use of silicon stents may not be necessary. This could potentially simplify the surgical procedure and reduce costs associated with stent placement and removal. However, the study was conducted in a specific setting – a single tertiary referral center in India – and involved a relatively tiny sample size. The results may not be generalizable to all populations or surgical practices.

The researchers acknowledge that their study is observational, meaning it cannot prove cause and effect. It’s possible that other factors, not accounted for in the study, contributed to the observed outcomes. For example, variations in individual anatomy or surgical technique could influence success rates. The study similarly notes the exclusion of patients with pre-existing sinonasal disease, which could limit the applicability of the findings to a broader patient population.

The Role of Endoscopy in Nasolacrimal Surgery

The increasing adoption of endoscopic techniques in nasolacrimal surgery is a significant development. As highlighted in the Cureus article, endoscopy offers several advantages over traditional methods, including reduced morbidity and improved post-operative quality of life. The use of zero-degree and 45-degree endoscopes, coupled with advanced camera and monitoring systems, allows surgeons to visualize the surgical field with greater precision and perform the procedure with minimal invasiveness. The study published on PubMed further details these methodological aspects.

Future Directions and Ongoing Research

Whereas this study provides valuable insights, further research is needed to confirm these findings and explore the optimal use of stents in endonasal DCR. Larger, multi-center trials with diverse patient populations are necessary to determine whether specific patient characteristics or surgical factors might predict who would benefit most from stenting. Investigating patient-reported outcome measures, such as tear volume and symptom severity, would also provide a more comprehensive assessment of treatment effectiveness.

Currently, there are no immediate changes to clinical practice guidelines expected based solely on this study. However, the findings contribute to the growing body of evidence informing surgical decision-making. Patients considering endonasal DCR should discuss the potential benefits and risks of stenting with their ophthalmologist or otolaryngologist to determine the most appropriate treatment plan for their individual circumstances. It’s crucial to remember that surgical decisions should always be made on a case-by-case basis, considering the patient’s overall health, anatomy, and preferences.